CIK 0001719406 · Non-accelerated filer<br>Smaller reporting company
NRX Pharmaceuticals, Inc.
Sign in to watch- Ticker
- NRXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822844431
- Phone
- 484-254-6134
- Business address
- 1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
- Former names
- Big Rock Partners Acquisition Corp.
- 8-K Event Material agreement · Regulation FD disclosure
- DEF 14A Proxy Proxy Statement
- 8-K Event Delisting notice
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- DEF 14A Proxy Proxy Statement
- 8-K Event Delisting notice
- 8-K Event Executive or director change
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- DEF 14A Proxy Proxy Statement
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 8-K Event Delisting notice
- DEF 14A Proxy Proxy Statement
- 8-K Event New debt or obligation · Other events
- 8-K Event Other events
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
Page 8 of 9 · 166 filings